POWL BRIAN T. (Chief Commercial Officer) sold 19.2% of their position (32.45K shares) of KURA ONCOLOGY, INC. on the open market
Open‑market sale worth $345.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/29/2026ACC: 0001193125-26-407935
Officer· Chief Commercial Officer
Since Jan 2026
-32.45K
Net shares
Net seller
$345.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
32.45K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−9.02K
Price / share
$10.50
Trade value
$94.69K
% of position
5.3%
9/28/2026
169.27K→160.25K
Common Stock
Direct
Shares
−8K
Price / share
$10.56
Trade value
$84.50K
% of position
5.0%
9/28/2026
160.25K→152.25K
Common Stock
Direct
Shares
−15.43K
Price / share
$10.75
Trade value
$165.85K
% of position
10.1%
9/29/2026
152.25K→136.82K
Total
Net shares
−32.45K
Net value
-$345.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2026 | S · Sale | −9.02K | $10.50 | $94.69K | 5.3% | 169.27K | 160.25K |
| Common Stock Direct | 9/28/2026 | S · Sale | −8K | $10.56 | $84.50K | 5.0% | 160.25K | 152.25K |
| Common Stock Direct | 9/29/2026 | S · Sale | −15.43K | $10.75 | $165.85K | 10.1% | 152.25K | 136.82K |
| Total | −32.45K | -$345.04K | ||||||
Derivative Transactions0
No derivative transactions reported